Company Overview
Snapshot
Founded in March 2006 by Yinon Shlomi, Adar Biotech operates with 1–10 employees. The company specializes in developing medical devices for enhanced drug delivery and homeland security applications, alongside providing research services.
Business overview
Adar Biotech develops miniature medical devices designed to enhance drug delivery and for homeland security/bioterrorism applications. The company also offers products and services to the research community, including the manufacture of functional resins and recombinant proteins, as well as immunological and cell-culture services. Adar Biotech specializes in generating monoclonal antibodies to challenging antigens, offering an immunology licensing package that includes an adjuvant, selection media, and screening technology. The company operates within the Health Tech & Life Sciences sector, with a focus on Drug Delivery and Medical Devices, serving B2B and B2G markets.
Log in to access full profile ›Company Intelligence Q&A
- What is Adar Biotech's primary focus?
- Adar Biotech primarily focuses on developing miniature medical devices for enhancing drug delivery and for homeland security/bioterrorism applications.
- What services does Adar Biotech provide to the research community?
- Adar Biotech provides products and services to the research community, including the manufacture of functional resins and recombinant proteins, and supplies customers with immunological and cell-culture services.
- What is Adar Biotech's expertise in immunology?
- Adar Biotech specializes in the generation of monoclonal antibodies to weak and difficult antigens, offering an immunology licensing package that includes an adjuvant, selection media, and screening technology.
- When was Adar Biotech founded?
- Adar Biotech was founded in March 2006.
- Who is the founder of Adar Biotech?
- Yinon Shlomi is the founder and CEO of Adar Biotech.